Detalhe da pesquisa
1.
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.
Nature
; 605(7910): 532-538, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35508657
2.
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study.
Am J Hematol
; 99(6): 1201-1204, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38563490
3.
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.
Lancet Oncol
; 23(1): 172-184, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34895481
4.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 378(14): 1277-1290, 2018 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29562145
5.
Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus.
J Virol
; 92(19)2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30045981
6.
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
N Engl J Med
; 370(3): 211-21, 2014 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-24428467
7.
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).
J Hepatol
; 64(5): 1011-1019, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26739688
8.
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
Gut
; 64(6): 948-56, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25080450
9.
Preliminary study of two antiviral agents for hepatitis C genotype 1.
N Engl J Med
; 366(3): 216-24, 2012 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-22256805
10.
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.
Gastroenterology
; 146(2): 420-9, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24184132
11.
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.
J Hepatol
; 60(3): 490-9, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24444658
12.
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
Blood Adv
; 8(10): 2433-2441, 2024 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38330179
13.
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.
J Infect Dis
; 206(7): 1002-11, 2012 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22896665
14.
Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score.
Eur Urol
; 83(5): 432-440, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36868932
15.
In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.
Antimicrob Agents Chemother
; 56(7): 3498-507, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22547625
16.
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade.
Clin Cancer Res
; 28(18): 4121-4130, 2022 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36106402
17.
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy.
Sci Adv
; 8(37): eabq5089, 2022 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36112691
18.
Soluble PD-L1 as an early marker of progressive disease on nivolumab.
J Immunother Cancer
; 10(2)2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35131863
19.
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma.
J Immunother Cancer
; 10(3)2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35304405
20.
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.
J Immunother Cancer
; 9(3)2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33658305